Completed NA INTERVENTIONAL 4-arm NCT00721136

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Sponsor: Johns Hopkins University

Conditions Atrial Fibrillation Bradycardia Tachycardia Valvular Heart Disease

Interventions Hold warfarin Warfarin held with heparin transition. continue warfarin through the procedure

Updated 10 times since 2017 Last updated: Jul 31, 2017 Started: Sep 30, 2007 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00721136, this NA trial focuses on Atrial Fibrillation and Bradycardia and remains completed. Sponsored by Johns Hopkins University, it has been updated 10 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2020 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Sep 2017 [monthly]

Completed NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Columbia, United States